Press Releases

FDA-approved Ethyol® and Totect® address harmful effects of cancer treatments to help improve the quality of life for oncology patients

Study supports use of Omeclamox®-Pak as first-line treatment for H. pylori

- National sales and distribution of Totect® initiated
- New Data on Caldolor® and Vaprisol® published
- Co-promotion for Kristalose® launched

NASHVILLE, Tenn. , Feb. 27, 2018 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2017 financial results after the market closes on Tuesday, March 6, 2018 .  A conference call and live Internet webcast will be held on

Amifostine may prevent gastro-intestinal toxicities in certain cancer patients.

- Launched Totect&#174; in the United States<br>- Implemented Kristalose&#174; Co-Promotion Agreement

NASHVILLE, Tenn. , Oct. 31, 2017 /PRNewswire/ --   Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release third quarter 2017 financial results after the market closes on Tuesday, November 7, 2017 .  A conference call and live Internet webcast will be held on Tuesday,

NASHVILLE, Tenn. and BURTON ON TRENT, England , Sept. 25, 2017 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX, 'Cumberland') and Clinigen Group plc (AIM:CLIN, ' Clinigen ') , announced today the promotional launch of Totect ® (dexrazoxane hydrochloride), in the U.S.

- Revenues Grew 17% Over the Prior Year Period<br>- New Co-Promotion Agreement for Kristalose&#174; added

NASHVILLE, Tenn. , Aug. 1, 2017 /PRNewswire/ --  Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release second quarter 2017 financial results after the market closes on Tuesday, August 8, 2017 .  A conference call and live Internet webcast will be held on Tuesday,